Lilly Continues Positive Outlook For Migraine Treatment

Posted: Updated:
INDIANAPOLIS -

Indianapolis-based Eli Lilly and Co. (NYSE: LLY) says a 12-month Phase 3 study of a migraine treatment has shown continued positive results. The pharmaceutical giant says the study for galcanezumab showed a "statistically significant reduction in the number of monthly migraine headache days" among patients.

Lilly says the treatment "demonstrated a positive safety and tolerability profile in patients with migraine, consistent with previous studies." Patients received two different doses and the company says there was "no clinically meaningful difference" in the rate of adverse effects between the dosages. 

Lilly's previously-announced plans to submit a Biologics License Application to the U.S. Food and Drug Administration remain set for the second half of 2017. The company also plans to submit to other regulatory agencies throughout the world.

"These long-term results are significant for the millions of Americans with migraine. They reinforce the efficacy and safety profile of galcanezumab while supporting its potential use as a self-administered, monthly injection," said Christi Shaw, president of Lilly Bio-Medicines. "After more than two decades of research, Lilly is excited to submit galcanezumab to the FDA as a new potential treatment option that can provide more migraine-free days for people suffering with migraine."

Lilly is presenting the results of the study at the 18th Congress of the International Headache Society in Vancouver. The company also plans to submit the findings for publication in a peer-reviewed journal "in the coming year."

The announcement comes just one day after Lilly detailed plans for a global restructuring, affecting about 3,500 employees. The company said the move will allow it to invest in the next generation of new medicines.

  • Perspectives

    • Making Numbers Work Harder For You

      Sencha CEO Art Landro believes the world has created more data in the last two years than in the preceding 5,000, and that we'll probably create even more than that before this year ends. In every aspect of our lives, we're absolutely drowning in data.

    More

Subscribe

Name:
Company Name:
Email:
Confirm Email:
HTML
INside Edge
Morning Briefing
BigWigs & New Gigs
Life Sciences Indiana
Indiana Connections
INPower
Subscribe
Unsubscribe

Events



  • Most Popular Stories

    • Indianapolis Among Amazon 'HQ2' Finalists

      Seattle-based Amazon.com Inc. (Nasdaq: AMZN) has named Indianapolis one of 20 finalists for the location of a second corporate headquarters. The company accepted bids late last year for what it expects to be a more than $5 billion investment that could bring up to 50,000 jobs with it. Chicago and Columbus, Ohio were the other two Midwest cities still in the running. Amazon says its "HQ2" will be "a full equal to our current campus in Seattle."

    • Anthem HQ Shifting to Different Downtown Location

      Indianapolis-based Anthem Inc. (NYSE: ANTM) says it is exiting from one of the city's most prominent office locations. Our partners at WIBC report the company is not renewing its lease at 120 Monument Circle, which has served as its primary corporate office since the early 1990s. The insurer's lease is set to run out at year's end and, without giving a timeline, a company spokesperson said...

    • Sony DADC to Lay Off Hundreds in Terre Haute

      Sony DADC has announced plans to lay off 375 workers at its Terre Haute facility. In a notice to the Indiana Department of Workforce Development, the company says the layoffs are due to its decision to outsource the music and video manufacturing operations at the facility. A spokeswoman for Sony DADC tells our partners at WTHI-TV the move will affect more than half the employees at the Vigo County location.

    • Hogsett: Amazon Announcement 'Speaks Volumes'

      Indianapolis Mayor Joe Hogsett says Seattle-based Amazon.com Inc. (Nasdaq: AMZN) choosing the city as one of 20 finalists for its second corporate headquarters shows Indy is "punching above our weight" as an attractive tech hub. He says Indianapolis is one of the least-populated metropolitan areas on the list. The project, announced late last year, is expected to bring a more than $5 billion investment and ultimately up to 50,000 jobs. In an interview with...

    • Committee Ices Carryout Cold Beer Bill

      The Senate Committee on Public Policy has voted down a bill that would've allowed carryout cold beer to be sold in additional locations like convenience stores, grocery stores and drug stores. The commission voted against Senate Bill 26 by a tally of 9-1 after three hours of testimony that mostly involved business owners and industry group representatives. Senator Tim Lanane () was the only yes vote, arguing for passage so the full Senate could make amendments.